|

Imatinib 400 MG Clinical Trials

2 actively recruiting trials

Also known as: Gleevec, Glivec®

Pipeline

Phase 2: 2

Top Sponsors

  • Centre Leon Berard1
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

  • Cancer2
  • Metastatic Gastrointestinal Stromal Tumor1
  • Locally Advanced Gastrointestinal Stromal Tumor (GIST)1
  • Unresectable Gastrointestinal Stromal Tumor (GIST)1
  • Rare Tumor1

Other2 trials

A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments
Phase 2
PLATFORM Study of Precision Medicine for Rare Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.